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Abstract  
 
Purpose: We explored the risk factors for glaucoma blindness among adults aged >40 years with 
primary glaucoma in Nigeria. 
Participants and methods: 13,591 participants aged >40 years were examined in the Nigeria 
National Blindness and Visual Impairment Survey; 682 (5.02%, 95CI 4.60-5.47%) had glaucoma by 
ISGEO’s criteria. This was a case-control study (n=890 eyes of 629 persons): glaucoma blind were 
cases and glaucoma not-blind were controls. Education level and occupation were used to determine 
socioeconomic status scores, which were divided into three tertiles (affluent, medium and deprived). 
We assessed socio-demographic, biophysical and ocular factors by logistic regression analysis for 
association with glaucoma blindness. Multinomial regression analysis was also performed with non-
glaucoma as the reference category. 
Results: 119/629 (18.9%; 95%CI 15.9-22.4%) persons were blind in both eyes, leaving 510 as 
controls. There was inter-ethnic variation in odds of blindness; age, male sex, socio-economic status, 
prior diagnosis of glaucoma, hypertension, intra-ocular pressure and lens opacity were associated 
with glaucoma blindness. Axial length, mean ocular perfusion pressure and angle-closure glaucoma 
were associated with blind glaucoma eyes. In multivariate analysis, Igbo ethnicity (OR2.79, 95%CI 
1.03-7.57) had higher risk as was being male (OR4.56, 95%CI 1.72-12.09), and unmarried (OR2.46, 
95%CI 1.03-5.93). Deprivation (OR3.72, 95%CI 1.55-8.93), prior glaucoma diagnosis (OR5.45, 
95%CI 1.67-17.74) and higher intraocular pressure (OR1.07, 95%CI 1.02-1.13) were also 
independent risk factors for glaucoma blindness. 
Conclusion: Approximately 1-in-5 people with primary glaucoma were blind, with ethnic variation in 
risk. Male sex and deprivation were strongly associated with blindness. Services for glaucoma need 
to improve in Nigeria, focussing on poor communities and men. 
Key words: glaucoma blindness; ethnicity; deprivation; risk factors; population-based; Nigeria.   
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Introduction  
 
Glaucoma is the leading cause of irreversible blindness worldwide.1 Although there are very few 
population-based blindness prevalence surveys in Africa,2 data suggest that the prevalence of 
glaucoma blindness in Africa is the highest in the world.3, 4 In sub-Saharan Africa, the proportion of 
people with glaucoma identified in population-based surveys who are blind is alarming. In Ghana 
(2001) 10% of participants aged 30 years and above with glaucoma were blind.5 Among participants 
aged 40 years and above, the proportion of people with glaucoma who were blind was 14% in 
Kongwa, Tanzania (1996),6 15% in Mamre, South Africa (1992),7 and 33% in Temba, South Africa 
(1998).8 Glaucoma occurs all over the world,9 but risks for glaucoma blindness vary.10, 11 Early 
diagnosis and treatment delay vision loss and prevent blindness from glaucoma12 as the rate of 
progression of optic nerve damage is slowed by treatment.13, 14 Recent advances in technology for 
diagnosing glaucoma, greater therapeutic options, and treatment monitoring have decreased the 
probability of glaucoma blindness in patients in the care system in industrialized countries.15 
Conversely, without treatment there is a very high rate of progression of visual field loss.16 Who goes 
blind from glaucoma is influenced by biomedical factors such as age at onset, duration of disease 
and rate of progression of glaucoma.17, 18 In many low income settings aggravating factors relating to 
the health care system include low provision of glaucoma services and access to services,17-20 poor 
quality of care,21 and inadequate compliance with treatment and follow-up,18, 20 the latter being 
compounded by low levels of education.22 Few studies of risk factors for glaucoma blindness have 
been undertaken in Africa where glaucoma has an earlier age of onset and a more aggressive 
course. Services for glaucoma are also inadequate and acceptance and compliance with treatment 
are low.  
 
The increase in susceptibility of retinal ganglion cells to premature death may be mediated by genetic 
factors which may also interact with environmental factors.23 Family studies and genome-wide 
association studies (GWAS) for open-angle glaucoma (OAG) have demonstrated genotype-
phenotype correlations of heritable ocular features such as central corneal thickness (CCT),24 optic 
disc size, vertical cup:disc ratio (VCDR)25 and intraocular pressure (IOP).26 However, only one 
molecular genetics study of glaucoma has been undertaken to date in Africa and the investigators did 
not observe significant association with any of the previously reported genes and loci in OAG cases 
in the Ghana study population.27 Determining variation in the susceptibility to and severity of 
glaucoma among different ethnic groups who share common ancestry, is a first step in assessing the 
role of genetic factors in the pathogenesis of OAG in Africa. In an earlier study arising from the 
Nigeria National Blindness and Visual Impairment Survey (hereafter referred to as the Nigeria 
Blindness Survey) 94% of glaucoma was undiagnosed and untreated, and the crude prevalence was 
significantly higher in the Igbo ethnic group (7.77%; 95%CI 6.57-9.16).28 In this paper we present 
findings on risk factors for blindness, including ethnic groups, among those identified with glaucoma 
during the Nigeria Blindness Survey. 
 
The Nigeria Blindness Survey was the largest population-based blindness survey ever undertaken in 
Africa, providing data on the major blinding diseases,29 including glaucoma which was the second 
commonest cause (16.7%).30 The prevalence of blindness in adults aged >40 years was 4.2% 
(95%CI 3.8-4.6)31 and the glaucoma-specific blindness prevalence was 0.7% (95%CI 0.6-0.9).30 
Systematic sample of 1-in-7 participants provided normative values32 for defining glaucoma using the 
International Society of Geographic and Epidemiology Ophthalmology (ISGEO) levels of evidence.33 
The prevalence of glaucoma of all types was 5.02% (95%CI 4.60-5.47), one-fifth of whom were blind 
in both eyes.28  
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Materials and Methods 
 
Details of the methods used in the Nigeria Blindness Survey,29 normative values for diagnosing 
glaucoma32 and the prevalence and types of glaucoma in Nigeria28 have been published; and data on 
risk factors for OAG have been accepted for publication. A summary of the clinical assessments, with 
particular reference to classification of glaucoma and how potential risk factors for glaucoma 
blindness were measured and categorised, are described here. 
 
Ethics 
Ethical approval was obtained from the Ethics Committee of the London School of Hygiene & 
Tropical Medicine and the Federal Ministry of Health, Nigeria. Informed consent was obtained from 
community leaders, heads of households and all participants. The study adhered to the tenets of the 
declaration of Helsinki. Persons with medical or eye conditions including glaucoma needing further 
assessment and treatment were referred to the nearest healthcare facility.  
 
Study design and study population 
The study design for the analysis of risk factors for glaucoma blindness was a case-control study: 
people with glaucoma that were blind in both eyes (visual acuity [VA] worse than 3/60 in the better 
eye) were classified as cases; and people with glaucoma but not blind were classified as controls. 
For analysis of risk of blindness in eyes with glaucoma, the cases were glaucoma eyes that were 
blind (VA worse than 3/60) and the controls were glaucoma eyes that were not blind. The analysed 
sample consisted of persons classified as glaucoma and with no identified features suggesting 
secondary glaucoma (Figure 1). A person was classified as having glaucoma if the condition was 
present in one or both eyes. The sample size calculated for the Nigeria Blindness Survey was 15,375 
persons aged >40 years in 310 clusters.29 
 
Data collection and clinical assessment 
Participants were invited to a temporary examination site set up within the community. All were 
interviewed to obtain relevant personal and socio-demographic data. Evidence of glaucoma surgery, 
presence of cataract and evidence of cataract surgery were noted. Some investigations were not 
possible in participants who could not come to the examination center and who were examined in 
their home.  
Glaucoma classification 
Glaucoma was classified according to the ISGEO criteria, using percentile distributions of VCDR, 
VCDR asymmetry and IOP in normal Nigerians, derived from the normative subset (n=1759) of this 
study population.32 The diagnosis of glaucoma started with VCDR findings. Level 1 classification 
required structural and functional evidence i.e. 97.5th percentile of the VCDR (>0.7) or VCDR 
asymmetry (>0.1) in our normal population and visual field loss typical of glaucoma. Level 2 required 
advanced structural damage i.e. 99.5th percentile VCDR (>0.75) or VCDR asymmetry (>0.2) in the 
absence of visual field evidence. Level 3 applied when the optic disc was not seen and visual field 
testing was not possible, and used: a) blindness (VA<20/400) with the 99.5th percentile IOP 
(>28mmHg), or b) diagnosed with/being treated for glaucoma. An additional level of evidence (level 
2b) was added where the optic disc was visualized but the VCDR was <99.5th percentile and there 
were no visual fields available, but there was other compelling evidence such as RAPD, high IOP 
and/or corneal edema. These cases were adjudicated by glaucoma specialists (RW and WN). A 
person was said to have glaucoma if there was glaucoma in one or both eyes.  
 
Visual acuity measurement and definition of blindness 
Presenting VA was assessed by a trained ophthalmic nurse using a reduced logMAR tumbling-E 
chart34, 35 at 4 meters. If the participant could not see any letters at 4 meters, testing was repeated at 
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1 meter. Participants unable to see any letters at 1 meter were assessed for counting fingers, hand 
movement or perception of light (PL) or no PL (NPL). Visual acuities were categorized using World 
Health Organization (WHO) definitions of blindness and visual impairment (VI)36 where blindness at 
the person level is defined as VA worse than 3/60 in the better eye. An eye was classified as blind if 
the VA was worse than 3/60 in the affected eye.  
 
Determining the cause of blindness 
All participants with a VA worse than 6/12 in one or both eyes were examined by the experienced 
ophthalmologist. All disorders that may have contributed to visual loss in each eye were determined 
from a list of disorders. The principal/main cause was then selected for each eye and then for the 
person in the order of most preventable cause first (e.g. corneal opacity) then most treatable (e.g. 
refractive errors, cataract) and then other avoidable causes (e.g. glaucoma). Causes of blindness 
were determined using the World Health Organization’s algorithm for use in surveys, which 
emphasizes treatable and preventable causes. In the Nigeria survey, glaucoma was only assigned as 
the cause if, in the view of the examiner, other more readily treatable causes, such as clinically 
significant cataract were not present.  For example, in a blind person with clinically significant 
cataract and glaucoma, the main cause of blindness would be cataract.  
 
In this paper, glaucoma blindness refers to a person with glaucoma in one or both eyes and with a 
VA of worse than 3/60 in the better eye. A blind glaucoma eye has glaucoma with VA worse than 
3/60 in the affected eye. 
 
Risk factors assessment and classification 
Variables were analysed as continuous (age, axial length, IOP and mean ocular perfusion pressure 
[MOPP]) or binary (sex, marital status, literacy, place of residence, history of glaucoma, presence of 
hypertension, random blood glucose level [RBG], lens opacity, type of glaucoma and history of 
glaucoma surgery); or categorised into groups (ethnicity, socio-economic status [SES], geo-political 
zone [GPZ], severity of hypertension and body mass index [BMI]).  
Participants were asked about their ethnicity, marital status, ability to read and/or write, education 
level and occupation. Ethnic groups represented by >200 participants were analysed separately 
(Fulani, Hausa, Ibibio, Ibo, Ijaw, Kanuri, Nupe, Tiv, Urhobo and Yoruba). Marital status was classified 
as married and unmarried (single, divorced or widowed). Being literate was any ability to read and/or 
write, otherwise the participant was classified as illiterate. Proxies were used to determine household 
SES. Occupations were ranked from zero (not employed) to seven (professional) and the highest 
level of school attended were from zero (no schooling) to four (tertiary education). The sum of these 
scores were calculated for each individual and the mean of sum of these ranks within the household 
was assigned as the SES score for each individual in order to take into account of heterogeneity and 
household size. The SES scores were further divided into 3 equal tertiles as deprived, medium and 
affluent. Rural place of residence was defined as a settlement with a population of <20,000 residents, 
and GPZ are the 6 administrative zones in Nigeria – North Central, North East, North West, South 
East, South South and South West.   
Blood pressure (BP) was measured with the Omron wrist instrument (Omron Healthcare Ltd, Milton 
Keynes, England). The average of three readings was used in analysis. Hypertension was defined as 
BP>140/90mmHg and severity was categorised using WHO categories: stage 1 for systolic/diastolic 
BP>140/90 mmHg, stage 2 >160/100 mmHg and stage 3 >180/110 mmHg.37 BMI was calculated by 
dividing body weight (kg) by height (m) squared and categorised according to the international 
classification i.e. underweight (<18.5 kg/m2), normal (18.5–24.9 kg/m2), overweight (25.0–29.9kg/m2) 
and obese (>30.0 kg/m2).38 Every 1-in-7 participants and all participants suspected to have diabetic 
retinopathy on examination had RBG tested with Omron one-touch ultra blood glucose meter (Omron 
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Healthcare Ltd, Milton Keynes, England), and grouped as normal (<11.1 mmol/L) or raised 
(>11.1mmol/L).39 
Ocular axial length was measured by ultrasound A-scan biometry (Bioline Biometer OPTIKON 2000 
S.p.A Roma, Italy) and IOP was measured by Goldmann applanation tonometry using standard 
methods. To explore the association of vascular perfusion and glaucoma blindness, MOPP was 
calculated from diastolic BP (DBP), systolic BP (SBP) and IOP as 2/3[DBP+1/3 (SBP-DBP)-IOP].40 
Lens grading was performed using the Mehra-Minassian41 and the WHO grading systems.42 Lens 
opacity was classified as positive if it was visually disabling and VA<6/12 in the affected eye. 
The type of glaucoma was determined by gonioscopy without corneal compression performed with 
Volk’s 1-mirror non-flanged lens and Van Herick’s (VH) method for the estimation of the anterior 
chamber (AC) angle.43 Grades 3 and 4 VH AC angle estimation had a 99.1% sensitivity and 93% 
positive predictive value in identifying open angles by gonioscopy (risk factors for OAG, paper 
submitted for publication). Thus glaucoma eyes in which Schwalbe’s line could be seen, or had 
grades 3 or 4 by VH estimation if gonioscopy was not done, were classified as OAG. Glaucoma eyes 
in which Schwalbe’s line could not be seen, or had grades 0, 1 or 2 by VH estimation if gonioscopy 
was not done, were classified as angle-closure glaucoma (ACG). The eyes were unclassified if there 
was no gonioscopy or VH estimation of the AC angle. Participants were asked about history of ocular 
surgery and examined for evidence of glaucoma surgery such as bleb and peripheral iridectomy.  
Statistical analysis 
Socio-demographic, biophysical and ocular factors were analyzed for associations with glaucoma 
blindness after identifying participants with primary glaucoma who were blind or not blind (Figure 1). 
Statistical analysis was performed using Stata/IC 13.0 (Stata Corp, College Station, TX).  
We examined the association between glaucoma blindness and each risk factor separately and 
report odds ratios (OR) with 95% confidence intervals. We also assessed associations between blind 
glaucoma eyes and each of the six ocular factors. We used logistic regression to assess the 
independent effect of each risk factor on glaucoma blindness and blind glaucoma eyes and report 
adjusted odds ratios and 95% confidence intervals. Likelihood ratio tests and joint Wald tests were 
performed to check the fit of the model and the effect of levels of categorical variables and those with 
missing data. We assessed the variance inflation factor (VIF) for the covariates. Collinear variables 
were not included in the same multiple logistic regression model. The following covariates were 
included and adjusted for in the main multivariable model for glaucoma blindness: age, sex, ethnicity, 
marital status, literacy, SES, rural/urban residence, history of glaucoma, BP, BMI, axial length, IOP, 
lens opacity and history of glaucoma surgery. The association of MOPP was explored in a model 
without BP and IOP. Associations for GPZ and type of glaucoma were explored in separate models. 
All eyes were analyzed to take into account bilateral cases and ocular variables for within-person 
correlation clustered for pairs of eyes, with robust standard errors.  
To determine associations for a glaucoma eye being blind, all ocular variables were included in the 
multivariate model.  
To explore the magnitude and direction of the relative risk ratios (RRR) of the two glaucoma 
outcomes (not-blind and blind) compared to the non-glaucoma group, we performed multinomial 
logistic regression analysis with the non-glaucoma subset as the reference category. The variables 
age-group, sex, ethnic group, marital status, literacy, SES and place of residence were included in 
the model. We tested the overall effect of each of the covariates and levels of ethnic group and SES 
on predicting the two glaucoma outcomes. The marginal predicted probability plot of glaucoma 
blindness by age-group with sex and with SES were produced. P-values <0.05 were considered as 
statistically significant. Missing values were excluded. 
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Results 
In the study sample, 12,909 participants did not have glaucoma: 11,651 (90.3%) had both optic discs 
assessed and classified as non-glaucoma (Figure 1). For eyes that VCDR could not be assessed 
(n=1751 eyes, 6.8%), there was no level 3 evidence for glaucoma. In this analysis of risk factors for 
glaucoma blindness 890 eyes of 629 participants were included (Figure 1): 119 had glaucoma 
(18.9%;95%CI 15.9-22.4) and blind in both eyes (cases); and 510 controls. A further 139 participants 
with glaucoma had monocular blindness. Nearly half of those with glaucoma (258; 41%) were 
therefore blind in at least one eye. Glaucoma was the main cause of blindness in both eyes of 60/119 
persons (50.4%) and in one eye of 31 persons. Thus glaucoma was the main cause of blindness in at 
least one eye of 91/119 (76.5%). Other main causes of blindness were cataract, optic atrophy and 
macular degeneration. The main cause of blindness at the person level in the 119 participants was 
glaucoma in 83 (70%) and cataract in 16 (13%)(Table 1). Of the 890 eyes with glaucoma included in 
the analysis there were a total of 323 (36.3%) blind eyes with glaucoma in 358 participants. 
Glaucoma blind persons were older (mean age 68.5 years/SD 13.3) than the non-blind (mean age 
63.4years/SD 13.0; p=0.0001)(Table 2). The number blind increased with increasing age up to the 
age-group 70-79 years.  
There was a higher proportion of unmarried glaucoma blind participants than married. Stratified by 
sex, among the 43 unmarried glaucoma blind, 33 (76.7%) were women (p<0.001). 
A history of prior glaucoma diagnosis was positive in 38/629 (6.0%) participants; 15.1% known to 
have glaucoma were blind compared with 3.9% of undiagnosed cases (Table 2). 
The likelihood ratio tests on categorical covariates: ethnic group across all levels (p=0.001), blood 
pressure groups (p=0.005) and socioeconomic status (p<0.001) indicate that these variables create a 
statistically significant improvement in the fit of the main multivariable model; whereas for BMI 
categories p=0.53 and type of glaucoma p=0.27. For the joint Wald test (ethnic, BPgp, BMI) p=0.001. 
Risk factors associated with glaucoma blindness 
Ethnicity and GPZ were not predictors of SES. In univariate analysis, people with glaucoma 
blindness were more likely to be older, male and in deprived households. They were also more likely 
to be known glaucoma and have hypertension, and the odds of blindness increased with increasing 
severity of hypertension. The Igbo, Hausa, Fulani and Ijaw ethnic groups had significantly higher 
odds of glaucoma blindness than the reference ethnic group (Yoruba). Higher IOP (OR1.06;95%CI 
1.04-1.08; p<0.001) and presence of visually disabling lens opacity (vdLO) (OR2.72;95%CI 1.89-
3.91; p<0.001) also increased the odds of glaucoma blindness (Table 3). 
In multivariate analysis, being male, unmarried, living in a deprived household, severe hypertension 
and higher IOP remained independent risk factors for glaucoma blindness. Being poor/deprived had 
three-and-half times higher odds of glaucoma blindness (OR3.57; 95%CI 1.46-8.72; p=0.005) than 
affluent participants. A prior diagnosis of glaucoma had a significantly higher odds of glaucoma 
blindness (OR5.89;95%CI 1.79-19.40; p=0.004) (Table 3). Being unmarried was also an independent 
risk factor with higher odds of being blind (OR2.50;95%CI 1.03-6.07; p=0.04). The Igbo, Fulani, Ijaw 
and Tiv ethnic groups had higher odds for glaucoma blindness than the Yoruba (reference group) 
(Table 3). 
Risk factors associated with blind glaucoma eyes 
About half of the eyes with glaucoma and vdLO were blind (206/415; 49.6%), and almost two-thirds 
of eyes with ACG were blind (42/66; 63.6%)(Table 4). There was evidence of glaucoma surgery in 
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19/629 (3.02%) participants of whom eight had surgery in both eyes (total 27/890 eyes); all of which 
were trabeculectomy. There was no significant difference in blindness status in eyes that had 
undergone trabeculectomy.  
In univariate analysis, longer axial length, higher IOP, lower MOPP, vdLO and ACG were significantly 
associated with blind glaucoma eyes. However, when adjusted for age, sex, ethnicity, marital status, 
SES, location and other factors in the multivariable model, only higher IOP (OR1.09;95%CI 1.05-
1.13) and vdLO (OR2.13;95%CI 1.36-3.33) remained independent risk factors. There was no 
statistically significant association between trabeculectomy and glaucoma blindness or blind 
glaucoma eyes. 
Relative risk of the two glaucoma outcomes (not-blind and blind) compared to non-glaucoma 
(Table 5) 
RRR>1 signifies that there is an increase in the outcome (not-blind or blind) when compared to the 
reference group, non-glaucoma; given that the other variables in the model are held constant. Table 
5 shows the frequency distribution and the RRR of the covariates for the two outcomes of glaucoma. 
The factors that increased the outcome for glaucoma are shown. 
Glaucoma not-blind relative to non-glaucoma 
Increasing age was the only independent factor that had an increased relative risk for glaucoma not-
blind compared to non-glaucoma; from RRR 1.84 (95%CI1.37-2.48) in the 50-59 years age-group to 
6.69 (95%CI4.63-9.67) in the 80+ year-olds (Table 5).  
Glaucoma blind relative to non-glaucoma 
Older age-groups were more likely to have glaucoma blindness, with a RRR increasing from 3.51 
(95%CI1.77-6.99) in the 60-69 years age-group to 10.08 (95%CI4.85-20.93) in the 80+ year-olds.  
The Igbo ethnic group had a non-statistically significant increase in relative risk for glaucoma not-
blind (RRR 1.18, 95%CI0.91-1.54; p=0.21) but were more likely to be glaucoma blind by a factor of 
3.71 (95%CI2.01-6.85; p<0.001). Males were more likely than females to be glaucoma blind 
compared to non-glaucoma with an expected increase by a factor of 3.00 (95%CI1.87-4.83). 
Deprivation did not increase the outcome of glaucoma not-blind (RRR0.94, 95%CI0.73-1.21). 
However, for people with glaucoma, the deprived were more likely than the affluent to be blind with 
glaucoma by a factor of 4.42 (95%CI2.50-7.80). The overall effect of SES was statistically significant. 
More specifically, we tested the effect of deprivation in predicting glaucoma not-blind and glaucoma 
blind and this showed that the effects were statistically different from each other, i.e. the deprived 
were not at higher risk than the affluent to have glaucoma but were more likely to be blind with it. The 
Igbo, Hausa and Fulani ethnic groups also showed different effects in outcome of glaucoma. (Table 
5).  
Figure 2 shows the marginal predicted probabilities of glaucoma blindness by increasing age and by 
SES. For a 70-79 year-old male, the average marginal probability of being glaucoma blind was about 
3.5% compared to 1% for a female of the same age-group. 
Compared to the affluent, deprivation increased the average marginal probability of glaucoma 
blindness by approximately 0.5% in the younger age-group, to 4% in 70-79 year age-group and over 
5% in the 80+ ages. 
Discussion 
To our knowledge, this is the first population-based study of risk factors for blindness among 
individuals with glaucoma in a black population in Sub-Saharan Africa. In this study the vast majority 
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of participants with glaucoma had undiagnosed and untreated disease (96%) at the time of the 
survey, and so the findings largely reflect the natural history of untreated glaucoma.  
A set of post-estimation statistical analysis tools that would aid the understanding, interpretation and 
presentation of the relationship between the assessed risk factors were used. Being of Igbo ethnicity 
was an independent risk factor for glaucoma blindness. The Fulani, Ijaw and Tiv ethnic groups had 
odds ratios with very wide confidence intervals hence we cannot draw meaningful conclusions on 
these. Those with higher IOP and vdLO, being male and those living in deprived households also had 
increased odds of blindness.  
Although there are over 250 languages spoken in Nigeria, each ethnic group has similar ancestry 
and may be of common genetic stock. As ethnic group did not correlate with socio-economic status, 
ethnic differences in risk of glaucoma blindness suggest that there may be genetic similarities that 
lead to more aggressive disease in some ethnic groups, in terms of higher IOP or greater 
susceptibility of the optic nerve head to glaucoma, or gene-environment interactions. In the Nigeria 
Blindness Survey, about half (56%) of the eyes with glaucoma had IOP <22mmHg (mean 
IOP+2SD),28 and there was variation in optic disc parameters as well as IOP among some ethnic 
groups.32 These data are being explored to assess whether different ethnic groups are at increased 
risk of normal tension glaucoma, which may reflect genetic susceptibility to structural optic nerve 
damage (as in the Japanese population, for example),44 or have differing frequencies of genetic 
variants such as CDKN2BAS associated with normal tension glaucoma.45 
Most of earlier studies have been retrospective, facility-based studies of glaucoma patients in the 
care system, showing that severity of glaucoma at diagnosis and poor control of IOP were key risk 
factors for progression to blindness.46-50 They buttress the paradigm that glaucoma visual loss could 
be prevented by earlier diagnosis and consistent and adequate treatment with IOP lowering as the 
cornerstone. Hospital reviews in Nigeria and sub-Saharan Africa also highlight factors that limit 
glaucoma patients’ ability to access or maintain treatment, thus worsening their visual prognosis.51-56 
One population-based study reported older age as the only factor associated with 
progression/severity of glaucoma in untreated individuals who were re-examined after 10 years of the 
initial survey.16  
In our study a staggering 1-in-5 people with glaucoma were already blind suggesting that services for 
glaucoma are either not available or poorly accessible. This is in contrast to data from a glaucoma 
clinic in Scotland, where glaucoma blindness was uncommon.57 In Norwich, Ang’s review of treated 
glaucoma patients reported 3.3% blind, none of whom was certified due to glaucoma.58 However, in 
Sweden glaucoma patients had a lifetime risk of glaucoma blindness of 15%.59 These studies did not 
include those undiagnosed in the population and may have overestimated the risk of glaucoma 
blindness.  
In our study, not all blindness was due to glaucoma and at least 13% could have been prevented by 
cataract surgery. Highlighting this and other causes underscores the need for providing non-
glaucoma interventions. The low cataract surgical coverage in this population60 compounds the 
problem. Hence there is a need for integrated comprehensive eye care services and high quality 
cataract surgery in patients with glaucoma.  
A surprising finding was that men were at a considerably higher risk of glaucoma blindness. This is 
likely to reflect the significantly higher prevalence of glaucoma in men (5.67%; 95%CI 5.05-5.47) than 
women (4.47%; 95%CI 3.98-5.00; p=0.002)28 and also an indication of general lack of availability or 
access to glaucoma services. Being unmarried was also an independent risk factor for glaucoma 
blindness, particularly among women. This finding probably reflects disempowerment of unmarried 
women whose health needs are not prioritized by other family members or the community. In our 
study, those living in deprived households were also at a considerably higher risk of glaucoma 
10 
 
blindness and poor old people were most affected. As in most studies and reviews of poverty and 
blindness, socio-economic status tends to influence health-seeking behavior, awareness and 
healthcare access.61-66 Rural/urban and GPZ location were not independent risk factors in this study, 
suggesting that services for glaucoma are equally poor across the country. As in the St Lucia study,16 
increasing age was associated with glaucoma blindness, but the association was not significant in 
multivariate analysis. This may signify that glaucoma occurs at an earlier age in Nigeria with 
blindness occurring across all age groups, as duration of disease is an important risk factor for 
blindness.49, 67 Blindness occurring at an earlier age has also been reported in the black population of 
Baltimore.68 
A prior diagnosis of glaucoma was independently associated with blindness. Many facility-based 
studies in Africa show that a high proportion of newly diagnosed glaucoma patients present with very 
advanced disease;19, 51-54, 69 and diagnosed cases were more severely affected than non-diagnosed 
cases in the population.13 This underscores the need for an integrated approach for earlier case-
finding in the community, and the need for services that are acceptable and affordable.  
There are some limitations in this study. The definition of blindness by VA alone would underestimate 
the total numbers blind from glaucoma. Including visual fields in the definition of blindness might have 
increased the estimates of blindness by up to 25%.70 SES was determined by proxy factors i.e. 
education and occupation rather than using asset scores or other measures as this was not feasible 
within the constraints of the survey. Data on the duration of glaucoma or of blindness were not 
collected, as these data would be subjective and unreliable.  
The combination of high prevalence of glaucoma, socioeconomic deprivation and lack of access to 
services means that in Nigeria glaucoma is often a blinding condition. The finding that some ethnic 
groups are at increased risk of glaucoma and of glaucoma blindness warrants further investigation 
from a molecular genetics perspective which may further our understanding of the pathogenesis of 
glaucoma in African populations and among those of African ancestry who live elsewhere.  
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Figure 1. Selection of Cases and Controls for Analysis of Risk Factors for Glaucoma 
Blindness and Classification of Glaucoma Eyes by Levels of Evidence 
 
 
 
Enumerated
15027
Respondents Non-response
13599 1428
Level 1
VCDR> 0.7
or asym>0.1 Analysed Excluded (no VA)
13591 8
303 eyes (90% response rate)
Level 2
VCDR> 0.75 Glaucoma Not glaucoma Disc graded in BE
or asym>0.2 682 (5.02%) 12909 11,651 90.30%
520 eyes Disc graded in OE
Primary glaucoma Secondary glaucoma 765 5.90%
Level 2b 629 persons 53
RAPD/Other 890 eyes Disc not graded in BE
evidence 493 3.80%
5 eyes Blind Not blind
(Cases) 119 (Controls) 510
Level 3
VA<20/400
IOP>28mmHg Cases 114 Controls 497
On treatment
62 eyes
Blind = VA<20/400 in the better eye
VA = visual acuity; BE = both eyes; OE = one eye; VCDR = verical cup:disc ratio; asym = VCDR asymmetry; RAPD = relative afferent pupillary defect; 
IOP = intraocular pressure. * = multinomial regression logistic sample includes primary and secondary glaucoma, 61 persons have missing data
Multiple logistic regression analysis sample (n=611)
Glaucoma blind 136 Glaucoma not blind 542 Not glaucoma 12,852
Multinomial logistic regression analysis sample (n=13,530)*
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Figure 2. Marginal Predicted Probabilities of Glaucoma Blindness by Age-Group With Sex 
and With Socioeconomic Status  
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Table 1. Main Causes of Blindness in Participants With Primary Glaucoma  
 
Main cause of blindness Number % 
Glaucoma 83 69.8 
Cataract 16 13.5 
Optic atrophy 6 5.1 
Macular degeneration 3 2.5 
Other posterior segment disease 3 2.5 
Corneal opacity 3 2.5 
Uncorrected aphakia 2 1.7 
Refractive error 1 0.8 
Anterior uveitis 1 0.8 
Unexplained  1 0.8 
Total 119 100.0 
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Table 2. Distribution Of Glaucoma Participants With and Without Blindness By Socio-
Demographic And Biophysical Factors (Total =629) 
Variable  Not blind n (%) 
510 (81.1%) 
Blind n (%) 
119 (18.9%) 
Socio-demographic factors    
Age group (years)      40 – 49 78 (15.3) 11 (9.2) 
      50 – 59 105 (20.6) 14 (11.8) 
      60 – 69 133 (26.1) 29 (24.4) 
      70 – 79 125 (24.5) 37 (31.1) 
      80+ 69 (13.5) 28 (23.5) 
      Mean+SD 63.4+13.0 68.5+13.3 
Sex      Female 268 (52.5) 43 (36.1) 
      Male 242 (47.5) 76 (63.9) 
Ethnic group      Yoruba 132 (26.1) 15 (12.6) 
      Igbo 112 (22.1) 30 (25.2) 
      Hausa 86 (17.0) 24 (20.2) 
      Fulani 16 (3.2) 10 (8.4) 
      Kanuri 12 (2.4) 4 (3.3) 
      Ijaw 10 (1.9) 5 (4.2) 
      Ibibio 9 (1.8) 2 (1.7) 
      Nupe 8 (1.6) 2 (1.7) 
      Tiv 8 (1.6) 3 (2.5) 
      Urhobo 7 (1.4) 0 (0.0) 
      Others 106 (20.9) 24 (20.2) 
Marital status      Married 355 (69.6) 76 (63.9) 
      Unmarried 155 (30.4) 43 (36.1) 
Literacy         Literate 182 (35.7) 41 (34.5) 
      Non-literate 328 (64.3) 78 (65.5) 
Socio-economic status      Affluent 138 (27.1) 17 (14.3) 
      Medium 192 (37.6) 20 (16.8) 
      Deprived 180 (35.3) 82 (68.9) 
Place of residence      Urban   116 (22.7) 30 (25.2) 
      Rural  394 (77.3) 89 (74.8) 
Geo-political zone      South south 85 (16.7) 15 (12.6) 
      North east 39 (7.6) 15 (12.6) 
      South west 129 (25.3) 18 (15.1) 
      North central 70 (13.7) 19 (16.0) 
      South east 103 (20.2) 24 (20.2) 
      North west 84 (16.5) 28 (23.5) 
History of glaucomaα      Not known glaucoma 490 (96.1) 101 (84.9) 
      Known glaucoma 20 (3.9) 18 (15.1) 
Biophysical factors    
Blood pressure (mmHg)     
<140/90 
     Normal  374 (73.6) 65 (55.6) 
                                            
>140/90 
     Hypertension  134 (26.4) 52 (44.4) 
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Random blood glucose        
<11.1 
     Normal  84 (96.5) 21 (95.5) 
(mmol/L)                             
>11.1 
     Diabetes  3 (3.5) 1 (4.5) 
Body mass index (kg/m2)   
18.5-24.9 
     Normal     303 (60.5) 71 (61.2) 
                                             
<18.5 
     Underweight 76 (15.2) 21 (18.1) 
                                             
25.0-29.9 
     Overweight 81 (16.1) 21 (18.1) 
                                             
>30.0 
     Obese 41 (8.2) 3 (2.6) 
Glaucoma surgery      Trabeculectomy 12 (2.4) 7 (5.9) 
      No surgery 498 (97.6) 112 (94.1) 
Type of glaucoma      OAG 360 (91.8) 102 (91.9) 
      ACG 32 (8.2) 9 (8.1) 
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Table 3a). Univariate and Multivariate Analysis of Risk Factors for Blindness Among Participants With Glaucoma: Socio-Demographic Factors 
 n (%) 
[95%CI] 
Univariate analysis Multivariate analysis  
 Odds 
Ratio 
95%CI p-value  Odds 
Ratio 
95%CI p-
value 
VIF 
Blind persons 119 (18.9)[15.9-
22.4] 
        
Age (years) (Min 40)  1.00    1.00   1.46 
 Increasing age  1.03 1.01-
1.05 
<0.001  0.99 0.96-1.02 0.48  
Sex Female 43 (13.8) 1.00 Referenc
e 
  1.00 Reference  1.95 
 Male 76 (23.9) 1.96 1.30-
2.96 
0.001  4.59 1.73-12.16 0.002  
Ethnic group Yoruba 15 (10.2) 1.00 Referenc
e 
  1.00 Reference  1.06 
 Igbo 30 (21.1) 2.36 1.21-
4.60 
0.01  2.79 1.03-7.57 0.04  
 Hausa 24 (21.8) 2.46 1.22-
4.95 
0.01  2.69 0.89-8.14 0.08  
 Fulani 10 (38.5) 5.50 2.12-
14.28 
<0.001  9.75 2.91-32.67 <0.001  
 Kanuri 4 (25.0) 2.93 0.84-
10.26 
0.09  2.83 0.62-13.00 0.18  
 Ijaw 5 (33.3) 4.40 1.33-
14.61 
0.02  15.02 1.17-
193.69 
0.04  
 Ibibio 2 (18.2) 1.96 0.39-
9.92 
0.42  2.43 0.29-20.36 0.41  
 Nupe 2 (20.0) 2.20 0.43-
11.34 
0.35  3.22 0.41-25.02 0.26  
 Tiv 3 (27.3) 3.30 0.79-
13.81 
0.10  7.92 1.65-37.99 0.01  
 Others 24 (18.5) 1.99 1.00-
3.99 
0.52  4.01 1.41-11.43 0.01  
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Marital status Married 76 (17.6) 1.00 Referenc
e 
  1.00 Reference  1.57 
 Unmarried 43 (21.7) 1.30 0.85-
1.97 
0.23  2.50 1.03-6.07 0.04  
 Literacy Literate 41 (18.4) 1.00 Referenc
e 
  1.00 Reference  1.43 
 Non-literate 78 (19.2) 1.06 0.69-
1.61 
0.80  1.03 0.49-2.19 0.08  
Socioeconomic  Affluent 17 (11.0) 1.00 Referenc
e 
  1.00 Reference  1.20 
Status Medium 20 (9.4) 0.85 0.43-
1.67 
0.63  0.50 0.17-1.49 0.21  
 Deprived 82 (31.3) 3.70 2.10-
6.53 
<0.001  3.57 1.46-8.72 0.005  
 Residence Urban 30 (20.6) 1.00 Referenc
e 
  1.00 Reference  1.08 
 Rural 89 (18.4) 0.87 0.55-
1.39 
0.57  1.48 0.65-3.37 0.36  
Geopolitical zone North-east 15 (27.8) 2.18 0.97-
4.90 
0.06  2.18 0.59-7.97 0.24  
 North-west 28 (25.0) 1.89 0.94-
3.79 
0.07  1.60 0.53-4.86 0.40  
 North-central 19 (21.4) 1.54 0.73-
3.25 
0.26  1.07 0.38-3.01 0.90  
 South-south 15 (15.0)  Referenc
e 
  1.0 Reference   
 South-east 24 (18.9) 1.32 0.65-
2.68 
0.44  0.87 0.30-2.56 0.80  
 South-west 18 (12.2) 0.79 0.38-
1.66 
0.53  0.54 0.17-1.67 0.28  
History of 
glaucoma 
Not known 101 (17.1) 1.00 Referenc
e 
  1.00   1.32 
 Known 18 (47.4) 4.37 2.23- <0.001  5.89 1.79-19.40 0.004  
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glaucoma 8.55 
VIF = variance inflation factor for covariates in the main multiple logistic regression model; mean VIF = 1.28 
 
Table 3b). Univariate and multivariate analysis of risk factors for blindness amongst participants with glaucoma: Biophysical factors 
 n (%) 
[95%CI] 
Univariate analysis  Multivariate analysis  
 Odds 
Ratio 
95%CI p-
value 
 Odds 
Ratio 
95%CI p-
value 
VIF 
Hypertension 
mmHg 
          
 <140/90 Normal 65 (14.8) 1.00 Reference   NI    
>140/90 Hypertension  52 (28.0) 2.23 1.47-3.38 <0.00
1 
     
Blood  pressure 
mmHg 
(severity)          
<140/90 Normal 65 (14.8) 1.00 Reference   1.00   1.03 
>140/90 – 160/100 stage 1 mild 24 (25.0 1.92 1.13-3.27 0.02  2.29 1.02-5.14 0.04  
>160/90 – 180/110 stage 2 
moderate 
15 (27.8) 2.21 1.15-4.25 0.02  1.59 0.64-3.93 0.32  
>180/100 stage 3 severe 13 (36.1) 3.25 1.57-6.75 0.002  3.53 1.25-9.98 0.02  
Random blood 
glucose 
mmol/L          
<11.1 Normal  21 (20.0) 1.00 Reference   NI    
>11.1   Diabetes  1 (25.0) 1.33 0.13-13.62 0.81      
Body mass index 
kg/m2 
(Categories)          
18.5-24.9 Normal 71 (19.0) 1.00 Reference   1.00   1.08 
<18.5   Underweight 21 (21.7) 1.18 0.68-2.04 0.56  0.73 0.34-1.54 0.40  
25.0-29.9 Overweight 21 (20.6) 1.11 0.64-1.91 0.72  0.90 0.40-2.01 0.80  
>30.0 Obese  3 (6.8) 0.31 0.09-1.04 0.06  0.49 0.09-2.62 0.41  
NI = not included in multivariable models. 
Table 3c). Univariate and multivariate analysis of risk factors for blindness amongst participants with glaucoma: Ocular factors 
 n (%) 
[95%CI] 
Univariate analysis  Multivariate analysis  
 Odds 95%CI p-  Odds 95%CI p- VIF 
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Ratio value Ratio value 
Axial length (mm) (Min 18) - 1.00    1.00   1.19 
 (Max 30) - 1.15 0.92-
1.43 
0.22  0.79 0.56-1.11 0.18  
IOP (mmHg) (Min 5) - 1.00    1.00   1.09 
(higher) (Max 50) - 1.06 1.04-
1.08 
<0.00
1 
 1.07 1.04-1.09 <0.001  
MOPP (mmHg) (Min 6) - 1.00    1.00    
 (Max 115) - 0.99 0.97-
1.00 
0.10  0.99 0.97-1.00 0.14  
Lens opacity Clear lens 31 (9.9) 1.00    1.00   1.22 
 Lens opacity 88 (27.9) 2.72 1.89-
3.91 
<0.00
1 
 1.36 0.78-2.35 0.28  
Type of glaucoma OAG 102 (22.1) 1.00    1.00    
 ACG 9 (22.0) 1.38 0.69-
2.77 
0.36  0.63 0.21-1.92 0.42  
Glaucoma 
surgery 
No surgery 112 (18.4) 1.00    1.00   1.23 
 Trabeculectomy  7 (36.8) 1.45 0.55-
3.96 
0.44  0.41 0.09-1.83 0.25  
IOP = intraocular pressure; MOPP = mean ocular perfusion pressure; OAG = open-angle glaucoma; ACG = angle-closure glaucoma. 
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Table 4.  Association of Ocular Factors with Glaucoma Blind Eyes 
 For blind eyes 
 Univariate analysis Multivariate analysis 
   Odds 
Ratio 
95%CI p-
value 
 Odds 
Ratio 
95%CI p-
value 
Eyes with glaucoma 
N = 890 eyes (100%) 
Not blind  
567 
(63.7%) 
Blind  
323 
(36.3%) 
       
Ocular factors*          
          
Axial length (mm) 
Mean+SD 
22.68+0.
87 
22.89+1.
28 
       
(Min 19.32) Min 
20.42 
Min 
19.45 
1.00    Referenc
e  
  
(Max 29.92) Max 
25.14 
Max 
29.92 
1.21 1.05-
1.40 
0.01  1.03 0.81-
1.32 
0.80 
          
IOP (mmHg) Mean+SD 20+9 28+13        
(Min 5)   1.00    Referenc
e  
  
(Max 50)   1.08 1.06-
1.09 
<0.00
1 
 1.09 1.05-
1.13 
<0.00
1 
          
MOPP (mmHg) 
Mean+SD 
50+15 44+17        
(Min 6)   1.00    Referenc
e  
  
(Max 98)   0.98 1.06-
1.09 
<0.00
1 
 1.00 0.98-
1.04 
0.77 
          
Lens opacity          
Clear lens 358 
(75.4) 
117 
(24.6) 
1.00    Referenc
e 
  
26 
 
Lens opacity 209 
(50.4) 
206 
(49.6) 
3.02 2.27-
4.01 
<0.00
1 
 2.13 1.36-
3.33 
0.001 
          
Type of glaucoma@          
OAG 423 
(62.0) 
259 
(38.0) 
1.00    Referenc
e 
  
ACG 24 (36.4) 42 (63.6) 2.86 1.69-
4.83 
<0.00
1 
 1.25 0.59-
2.67 
0.56 
          
Glaucoma surgery@          
No surgery 553 
(64.1) 
310 
(35.9) 
1.00    Referenc
e  
  
Trabeculectomy  14 (51.9) 13 (48.2) 1.66 0.77-
3.57 
0.20  0.71 0.20-
2.52 
0.60 
          
*analysis adjusted for within person correlation; SD = standard deviation; IOP = intraocular pressure; MOPP = 
mean ocular perfusion pressure; @ = missing data excluded; OAG = open-angle glaucoma; ACG = angle-closure 
glaucoma.  
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Table 5. Relative Risk Ratios of the Glaucoma Outcomes (Glaucoma Not-blind and Glaucoma Blind) Compared to the Non-glaucoma Group  
 Frequency distribution (%) Relative Risk Ratio (RRR) Effect on 
predicting 
glaucoma 
outcome. 
p<0.05 if the 
effect is 
different on 
the 2 
outcomes 
Non-
glaucoma 
N (%) 
Glaucoma 
not blind 
N (%) 
Glaucoma 
blind 
N (%) 
Glaucoma not-blind  Glaucoma blind 
RRR 95%CI p-value  RRR 95%CI p-value 
Total 12909 
(94.98) 
546 (4.02) 136 (1.00)        
Socio-
demographic 
factor 
          
Age-group 
(years) 
           
    50-59 3447 (96.37) 112 (3.13) 18 (0.50) 1.85 1.37-248 <0.001  1.77 0.85-3.70 0.13  
    60-69 2595 (93.58) 147 (5.30) 31 (1.12) 3.13 2.34-4.20 <0.001  3.51 1.77-6.99 <0.001  
    70-79 1475 (89.23) 134 (8.11) 44 (2.66) 5.10 3.73-6.99 <0.001  7.43 3.75-14.71 <0.001  
    80+ 596 (85.26) 72 (10.30) 31 (4.43) 6.69 4.63-9.67 <0.001  10.08 4.85-20.93 <0.001  
            
Male 5892 (94.33) 267 (4.27) 87 (1.39) 1.15 0.92-1.42 0.23  3.00 1.87-4.83 <0.001  
            
Ethnic groups            
    Igbo 1769 (92.23) 116 (6.05) 33 (1.72) 1.18 0.91-1.54 0.21  3.71 2.01-6.85 <0.001 <0.001 
    Hausa 3245 (96.15) 97 (2.87) 33 (0.98) 0.62 0.48-0.81 0.001  1.94 1.05-3.56 0.03 <0.001 
    Fulani 810 (96.43) 18 (2.14) 12 (1.43) 0.47 0.29-0.78 0.003  2.39 1.11-5.14 0.03 <0.001 
    Ibibio 200 (94.34) 10 (4.72) 2 (0.94) 1.14 0.59-2.23 0.70  2.30 0.51-10.47 0.28 0.40 
            
Unmarried 2619 (92.51) 164 (5.79) 48 (1.70) 1.05 0.82-1.33 0.71  1.85 1.14-3.00 0.01  
            
Deprived 4191 (93.44) 199 (4.44) 95 (2.12) 0.94 0.73-1.21 0.63  4.42 2.50-7.80 <0.001 <0.001 
            
 
